Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial

• Heiner K. Berthold ,

  Contributed equally to this work with: Heiner K. Berthold, Manfredi Rizzo

  * E-mail: heiner.berthold@evkb.de

  Affiliation Department of Internal Medicine and Geriatrics, Bielefeld Evangelical Hospital (EvKB), Bielefeld, Germany

  ⨯
• Manfredi Rizzo ,

  Contributed equally to this work with: Heiner K. Berthold, Manfredi Rizzo

  Affiliations BioMedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy, Euro-Mediterranean Institute of Science and Technology, Palermo, Italy

  ⨯
• Nadine Spenrath,

  Affiliation Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany

  ⨯
• Giuseppe Montalto,

  Affiliation BioMedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy

  ⨯
• Wilhelm Krone,

  Affiliation Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany

  ⨯
• Ioanna Gouni-Berthold

  Affiliation Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany

  ⨯